Document Detail


Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
MedLine Citation:
PMID:  12198668     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The objective of this study was to compare sociodemographic, drug, and sexual risk characteristics between hepatitis C virus (HCV) baseline positive and negative young (13-24 years) injection drug users (IDUs) and to determine prospective risk factors for HCV seroconversion among the youth. Data were collected through the Vancouver Injection Drug Users Study (VIDUS). To date, more than 1,400 Vancouver-area IDUs have been enrolled and followed up; 234 were aged 24 years and younger. Semiannually, participants have completed an interviewer-administered questionnaire and have undergone serologic testing for human immunodeficiency virus (HIV) and HCV. Univariate and multivariate logistic regression analyses were undertaken to investigate predictors of baseline HCV positivity. In the multivariate analyses, Cox regression models with time-dependent covariates were used to identify predictors of HCV seroconversion. Of the 232 young injectors, 107 (46%) were HCV positive at baseline and a further 37 HCV seroconverted during the study period for an incidence rate of 37.3 per 100 person-years. Baseline positivity was associated with Aboriginal ancestry, older age, greater number of years injecting drugs, recent incarceration, sex trade work, more than 100 lifetime sexual partners, a previous sexually transmitted disease, living in the IDU epicenter, and injection more than once per day of heroin, cocaine, and speedball. Factors independently associated with HCV seroconversion were having a partner who uses injection drugs, requiring help to inject, and injection of cocaine more than once daily. In conclusion, unlike older IDUs, more than one half of young injectors were HCV negative at recruitment. Thus, there is a window of opportunity for prevention. However, the incidence rate of HCV among these young IDUs is alarming, suggesting that the opportunity to intervene is exceedingly small.
Authors:
Cari L Miller; Caitlin Johnston; Patricia M Spittal; Kathy Li; Nancy Laliberté; Julio S G Montaner; Martin T Schechter
Related Documents :
9261488 - Hiv infection risks, behaviors and methadone treatment: client-reported hiv infection i...
18096448 - Risk factors for hepatitis c virus infection in individuals infected with the hiv.
8207658 - In vitro activity of readily available household materials against hiv-1: is bleach eno...
2614398 - Cocaine injection and ethnicity in parenteral drug users during the early years of the ...
17374898 - Clinical and microbiological features of nocardiosis 1997-2003.
21651798 - Occupational segregation, gender essentialism and male primacy as major barriers to equ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hepatology (Baltimore, Md.)     Volume:  36     ISSN:  0270-9139     ISO Abbreviation:  Hepatology     Publication Date:  2002 Sep 
Date Detail:
Created Date:  2002-08-28     Completed Date:  2002-09-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8302946     Medline TA:  Hepatology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  737-42     Citation Subset:  IM    
Affiliation:
British Columbia Centre for Excellence in HIV/AIDS, University of British Columbia, Vancouver, British Columbia, Canada. cari@hivnet.ubc.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Cohort Studies
Female
Follow-Up Studies
Hepatitis C / epidemiology*,  prevention & control*
Humans
Incidence
Logistic Models
Male
Prevalence
Proportional Hazards Models
Risk Factors
Seroepidemiologic Studies
Sexual Behavior
Socioeconomic Factors
Substance-Related Disorders / epidemiology*,  virology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.
Next Document:  The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infe...